systolic dysfunction

systolic dysfunction

a loss of cardiac muscle with volume overload and decreased contractility.
References in periodicals archive ?
IVRT was within normal range in 20 patients and it was < 60 msec in 10 patients who also had coexisting LV systolic dysfunction with ejection fraction of < 50%.
MELBOURNE, Australia, December 21, 2017 -- Mesoblast Limited (MESO) announced that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation for its novel mesenchymal precursor cell (MPC) therapy in the treatment of heart failure patients with left ventricular systolic dysfunction and left ventricular assist devices (LVADs).
MELBOURNE, Australia December 21, 2017 -- Mesoblast Limited (MESO) announced that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation for its novel mesenchymal precursor cell (MPC) therapy in the treatment of heart failure patients with left ventricular systolic dysfunction and left ventricular assist devices (LVADs).
The topic of his poster was "Incidence of obstructive Coronary Artery Disease in patients without known coronary disease undergoing coronary angiography for evaluation of Left Ventricular Systolic Dysfunction at a Tertiary Cardiac Care Center in Pakistan".
As in SPRINT, patients with baseline heart failure, stroke, systolic dysfunction, diabetes, end-stage renal disease, and cancer were among those excluded.
Statistical assessment showed positive relationship between severity of asphyxia and systolic dysfunction (P=0.
Thrombus formation in the LV generally occurs because of diseases that cause LV systolic dysfunction.
Left ventricular systolic dysfunction in childhood can be due to many causes.
2%) with a diagnosis of CHF due to left ventricular systolic dysfunction.
It is evaluating MPC-150-IM in adult patients with moderate to advanced New York Heart Association (NYHA) Class II/III chronic heart failure with left ventricular systolic dysfunction.
Tenax said that the full LEVO-CTS trial design was recently published by the study's investigators in the American Heart Journal in an article titled, "Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery on Cardiopulmonary Bypass: Rationale and Study Design of the LEVO-CTS Trial.

Full browser ?